AARDVARK THERAPEUTICS
Dead / Abandoned — Notice of allowance cancelled — returned to examination (as of 28 Apr 2026)
What this means for you
This application is over — abandoned 24 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98979189
- Mark type
- Stylized text
- Filed
- 16 Nov 2024
- Published for opposition
- 29 Jul 2025
- Abandoned
- 24 Mar 2026
- Attorney of record
- Elise Wu
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.
Owner
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
Prosecution history
- 16 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Apr 2026 — NOTICE OF ALLOWANCE CANCELLED
- 15 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2026 — CORRECTED NOA E-MAILED
- 15 Sept 2026 — DIVISIONAL PROCESSING COMPLETE
- 23 Mar 2026 — DIVISIONAL REQUEST RECEIVED
- 29 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Aug 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Aug 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 03 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jul 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 22 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Mar 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT